ArticleDiscover oncology2026
Impact of COVID-19 vaccination on radiation-induced lung injury in breast cancer patients: a retrospective cohort study.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe safety of COVID-19 vaccination during radiotherapy remains a concern among oncologists. This study investigates whether vaccination increases the risk of radiation-induced lung injury (RILI) in breast cancer patients.
methodsWe retrospectively analyzed 157 breast cancer patients treated with radiotherapy between April 2021 and October 2022. Lung injury was assessed through post-treatment imaging and correlated with COVID-19 vaccination status.
resultsOf 157 patients, 70 (44%) developed radiologic signs of radiation induced lung injury. Most patients (85%) were vaccinated. Statistical analysis revealed no significant association between vaccination status and injury risk (Chi-square p = 0.3569; logistic regression p = 0.646, OR = 1.063, 95% CI: 0.821-1.383). A non-significant trend toward reduced injury was noted in the two-dose subgroup.
conclusionThe findings of this study indicate that the administration of the COVID-19 vaccine prior to the commencement of radiation therapy is not associated with an increased likelihood of pulmonary toxicity. Although a slight protective effect was observed with two vaccine doses, it was not statistically significant. The retrospective nature of the study and the limited sample size necessitate the execution of larger, prospective, long-term follow-up studies to elucidate the underlying immunological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.